Get App
Download App Scanner
Scan to Download
Advertisement
LIVE UPDATES

Sensex, Nifty End Higher Led By Autos, Banks

Sensex, Nifty End Higher Led By Autos, Banks
A bronze bull statue stands at the entrance to the Bombay Stock Exchange (BSE) building in Mumbai, India. (Photographer: Dhiraj Singh/Bloomberg)
5 years ago
Catch all live updates on share prices, index moves, corporate announcements and more from the Sensex and Nifty, today. 

Indian equity markets ended higher for the fourth straight day, led by a rally in the final hour.

The S&P BSE Sensex ended 0.6% higher at 39,073 while the NSE Nifty 50 index ended 0.66% higher at 11,548.

Tomorrow will be the F&O expiry session of the August series.

Banks and Autos were the outperformers in today's session. The Nifty Auto ended 1.5% higher led by Tata Motors and two-wheeler stocks while the Nifty Bank ended 1.4% higher. The Nifty Bank is now up 1,400 points in the last four trading sessions.

The Media index was the top sectoral gainer, ending 2.5% higher. Nifty FMCG and Nifty Pharma ended flat but with a negative bias.

The midcap and smallcap indices ended higher for the eighth straight session - the longest winning streak since January this year. The midcap index gained 0.5% while the smallcap index ended 1% higher.

India Volatility Index ended 0.4% higher at 19.39.

Market breadth was in favour of the gainers. 1,076 stocks on the NSE ended with gains while 752 posted losses.

  • Trading at the highest point of the day
  • Gains as much as 6.6% to Rs 624
  • Biggest single-day gain in four months
  • Trades at the highest level in five months
  • Gains for the fifth straight day
  • Has gained in 11 out of the last 13 trading sessions
  • Up 25% in the last 13 trading sessions
  • Today's volumes are 94% higher than its 20-day average
  • Stock in overbought territory with Relative Strength Index (RSI) at 83
  • Stock nearing its 200-Day Moving Average of 642.7
  • Has gained over 50% from its 52-week low of Rs 408.9 on March 24, 2020
  • 12 out of the 26 analysts tracking the stock have a buy recommendation
  • The stock trades 17.8% higher than its 12-month consensus price target of Rs 505, implying a negative return potential

  • Trades at an all-time high
  • Gains as much as 9.8% to Rs 3,600
  • Has gained in three out of the last four trading sessions
  • Up 20% in the last four trading sessions
  • Today's volumes are 63% higher than its 20-day average
  • Stock trades in overbought territory with Relative Strength Index (RSI) at 83
  • Has gained over 400% from its 52-week low of Rs 716.5 on August 26, 2019
  • All three analysts tracking the stock have a buy recommendation
  • The stock trades 4.4% higher than its 12-month price target of Rs 3,355, implying a negative return potential

The drugmaker along with Mylan have announced the launch of Nepexto's biosimilar etanercept in the German market.

Nepexto is used in the treatment of moderate to severe active rheumatoid arthritis, moderate to severe plaque psoriasis and chronic severe plaque psoriasis.

Nepexto is available as an injectable in an easy-to-use pre-filled pen and a pre-filled syringe, as per its exchange filing.

Shares gained as much as 1.5% to Rs 986.2, before cooling off.

The company has informed the exchanges that it has won an order worth Rs 1,157 crore from the Tamil Nadu Government.

The order involves the construction of an elevated highway along Avinashi road in Coimbatore city from Goldwins to Upplipalayam, the company said in an exchange filing.

The project is scheduled to be completed within a period of 48 months from the appointed date.

Shares recovered from the day's low to gain as much as 2.4% to Rs 272.5, post the announcement. The stock is up for the fourth straight day.

  • Second best performer on the Nifty 500 index
  • Gains as much as 13.7% to Rs 1,539
  • Trades at the highest level in six months
  • Sustaining above its 200-Day Moving Average at 1,302 for the ninth straight session
  • Today's volumes are 90% higher than its 20-day average
  • Trading in overbought territory with Relative Strength Index (RSI) at 78
  • Has more than doubled from its 52-week low of Rs 580 on March 24, 2020
  • Both analysts tracking the stock have a buy recommendation
  • Return potential of the stock as per Bloomberg data is 31%

  • Up for the third straight day
  • Gains as much as 10.8% to Rs 533.6
  • Biggest single-day gain in four months
  • Trading at the highest level in six months
  • Has gained 18% in the last three trading sessions
  • Today's volumes are five times higher than its 20-day average
  • Breaks out above its 200-Day Moving Average at 481
  • Stock in overbought territory with Relative Strength Index (RSI) at 82
  • Has more than doubled from its 52-week low of Rs 219.2 on March 24, 2020
  • Two out of the three analysts tracking the stock have a buy recommendation
  • The stock trades 16.8% higher than its 12-month consensus price target of Rs 431.3, implying a negative return potential

  • Benchmark indices gain momentum
  • Nifty up 0.43% at 11,521
  • Sensex up 0.34% at 38,974
  • Nifty Bank up 1% at 23,316
  • Nifty Midcap index up 0.7%
  • Nifty Smallcap index up 1.2%
  • India Volatility Index down 0.4% at 19.2
  • Nifty Media extends gains as the top sectoral gainer; up 2.4%
  • Nifty Auto is the other major sectoral gainer; up 1.6%
  • Nifty FMCG and Nifty Pharma are the only sectoral laggards, down 0.3% each
  • Tata Motors remains the top Nifty gainer; up 7%
  • Bharti Airtel remains the top Nifty laggard; down 2.7%
  • 1,081 stocks on the NSE trade with gains while 715 stocks decline

  • Reliance Industries' 2,100 Call: Premium up 60.3% to Rs 26.3. The contract has shed 1,542 shares in Open Interest.
  • Bajaj Finance's 3,700 Call: Premium down 58.8% to Rs 12.3. The contract has shed 250 shares in Open Interest.
  • Tata Motors' 135 Call: Premium up 100% to Rs 1.7. The contract has added 33 shares in Open Interest.

  • Top gainer on the Nifty Auto index
  • Second best performer on the Nifty 50 index
  • Gains as much as 6.4% to Rs 135.2
  • The stock trades at the highest level in six months
  • Up for the third straight day
  • Has gained 12% in the last three trading sessions
  • Breaks above its 200-Day Moving Average at 126.9
  • Today's volumes are triple its 20-day average
  • Stock in overbought territory with Relative Strength Index (RSI) at 70
  • Has doubled from its 52-week low of Rs 63.5 on March 24, 2020
  • 17 out of the 37 analysts tracking the stock have a buy recommendation
  • The stock trades 10.8% higher than its 12-month consensus price target of Rs 119.5, implying a negative return potential

Nifty Bank: August 27 Expiry
  • 23,500 Call: Premium up 20% to Rs 60.4. The contract has added 30,715 shares in Open Interest.
  • 23,000 Put: Premium down 43.6% to Rs 95. The contract has added 39,052 shares in Open Interest.
  • 23,300 Call: Premium up 26.5% to Rs 128.7. The contract has added 10,623 shares in Open Interest.

  • Trades at the highest level since September 2018
  • Gains as much as 4.3% to Rs 66.5
  • Up for the fourth straight day
  • Has gained 17% in the last four trading sessions
  • Today's volumes are 67% higher than its 20-day average
  • Stock in overbought territory with Relative Strength Index (RSI) at 80
  • Has tripled from its 52-week low of Rs 20 on March 24, 2020
  • Four out of the six analysts tracking the stock have a buy recommendation
  • The stock trades 13% higher than its 12-month consensus price target of Rs 57.5, implying a negative return potential

Let's take a look at how benchmark indices across Europe have opened:

  • Euro Stoxx 50 down 0.4% at 3,316
  • DAX down 0.4% at 13,011
  • CAC down 0.6% at 4,877
  • FTSE 100 down 0.5% at 6,008
  • IBEX 35 down 0.4% at 7,080

  • Among the top performers on the Nifty Midcap index
  • Gains as much as 8.1% to Rs 223
  • Biggest single-day gain in two months
  • Up for the second straight day
  • Trades at the highest level in a month
  • Breaks above its 200-Day Moving Average at 217
  • Today's volumes are quadruple its 20-day average
  • The stock has nearly tripled from its 52-week low of Rs 81 on March 20, 2020
  • One out of the four analysts tracking the stock have a buy recommendation; 1 sell call
  • The stock trades 27% higher than its 12-month consensus price target of Rs 160, implying a negative return potential

India's largest seller of Plyboards - Century Plyboards Ltd. is witnessing sales rise towards levels seen in the pre-pandemic era, with demand from villages, Bloomberg News reports.

The Kolkata-based company estimates revenue in the second quarter to be as much as 75% of the same period during 2019 and may recover completely by March, Executive Director Keshav Bhajanka told Bloomberg News over phone.

Bhajanka, however declined to predict when will growth resume.

"The company was able to do well in June and July because the upcountry markets have done better probably since the infection is lower there," he said.

Bhajanka also believes that overseas sales will be back on track this quarter.

The company holds 25% of India's organised plywood market and exports mainly to South-east Asian countries.

  • Benchmark indices continue to remain sluggish
  • Nifty unchanged at 11,480
  • Sensex unchanged at 38,830
  • Nifty Bank up 0.7% at 23,246
  • Nifty Midcap index up 0.7%
  • Nifty Smallcap index up 1%
  • India Volatility Index up 0.6% to 19.43
  • Nifty Media and Nifty Auto are the top sectoral gainers; up 1.7% each
  • Nifty Metal and Nifty Realty up 1.2% each
  • Nifty FMCG and Nifty Pharma are the sectoral laggard; down 0.3% each
  • Tata Motors is the top Nifty gainer; up 6%
  • Bharti Airtel remains the top Nifty laggard; down 2.4%
  • 1,061 stocks on the NSE trade with gains while 697 decline

  • Top gainer on the Nifty 500 index
  • Gains as much as 19.3% to Rs 329.4
  • Biggest single-day gain on record
  • Trades at the highest level since July 2019
  • Up for the third straight day
  • Has gained 25% in the last three trading sessions
  • Broke above its 100-Day Moving Average at 270 on Tuesday
  • Today's volumes are 90 times higher than its 20-day average
  • Stock in overbought territory with Relative Strength Index (RSI) at 77
  • Stock has doubled from its 52-week low of Rs 166 on December 10, 2019
  • Two out of the six analysts tracking the stock have a buy recommendation
  • The stock trades 24.4% higher than its 12-month consensus price target of Rs 239, implying a negative return potential

The drugmaker announced on Tuesday that it has launched two variants of the Covid-19 drug Favipiravir - PiFLU and Favenza which will be used in the treatment of mild to moderate cases of Covid-19 in India.

Both drugs are currently available across the country, the company said in a filing.

The DGCI had approved the use of Favipiravir - an oral anti-viral drug to treat patients in India with mild to moderate symptoms.

“This will be a very positive development for FDC,” Yash Gupta of Angel Broking wrote in a note.

Shares gained as much as 6.4% to Rs 337.8 and have snapped a four-day losing streak.

The company has informed the exchanges that it has won a contract from the Singapore Government to build a digital and cloud-based commuter survey platform for its Land Transport Authority (LTA).

The total value of the contract is over $1 million, as per the company's exchange filing. The company is engaged on six projects across multiple Singapore government agencies as on date.

“These wins are significant validation of our Affle2.0 verticalization strategy and strengthen our long-term growth trend,” Chairman, MD & CEO Anuj Khanna Sohum was quoted as saying.

The stock is locked in a 5% upper circuit at Rs 2,943. This is the fourth straight day of upper circuits for the stock.

The last three sessions had seen upper circuits of 10%, post which the price band was revised to 5%. The stock is trading at an all-time high.

  • Top performing stock on the Nifty Smallcap index
  • Gains as much as 7.8% to Rs 566
  • Biggest single-day gain in two months
  • Trades at the highest level in six months
  • Up for the third straight day
  • Has gained in six out of the last eight trading sessions
  • Up 16% in the last eight trading sessions
  • Today's volumes are seven times higher than its 20-day average
  • Stock in overbought territory with Relative Strength Index (RSI) at 77
  • Sustains above its 200-Day Moving Average after breakout on August 18
  • Has more than doubled from its 52-week low of Rs 250 on March 24, 2020
  • All four analysts tracking the stock have a buy recommendation
  • The stock is trading at its 12-month consensus price target of Rs 557.5

The largest manufacturer of Quartz Kitchen Sinks in India, announced that it will be expanding its production capacity of Quartz Kitchen sinks by 20%.

The brownfield expansion will take place at the company's Bhavnagar plant, the exchange filing said.

The expansion will lead to an increase in capacity to 6 lakh units per annum from the current 1 lakh units per annum.

The company attributed the need for expansion to meet the increasing demand from the export market.

The company's export business contributed to 73% of the total revenue as of March 31, 2020.

It intends to finance the envisaged capex of Rs 15 crore through internal accruals. The expansion project is likely to be commissioned by March 2021, the exchange filing said.

Shares of the Rs 342 crore market-cap company rose as much as 5% to Rs 128.3 and are trading at the highest level in six months.

Shares fell as much as 3.2% to Rs 93.75, snapping a three-day gaining streak.

  • Up for the second straight day
  • Gains as much as 18.3% to Rs 128.9
  • Biggest single-day gain in over two months
  • Trades at the highest level in six months
  • Up 22% in the last two trading sessions
  • Closed above its 200-Day Moving Average of 106.9 on Tuesday and now sustaining above it
  • Today's volumes are 40 times higher than its 20-day average
  • Stock in overbought territory with Relative Strength Index (RSI) at 81
  • More than doubled from its 52-week low of Rs 51.1 on March 25, 2020
  • The stock trades near its 12-month consensus price target of Rs 120

2.29 crore shares of the company exchanged hands in nine large trades, as per Bloomberg data.

The amount of shares that exchanged hands amount to 3.65% of the total equity.

Buyers and sellers of the trade remain unknown.

The stock gained as much as 6% to Rs 19.6 and is trading at the highest level since July 2019. The stock is up for the 14th straight day - the most on record.

  • Benchmark indices give up gains to trade flat
  • Nifty unchanged at 11,465
  • Sensex down 0.2% at 38,782
  • Nifty Bank up 0.64% at 23,235
  • Nifty Midcap index up 0.4%
  • Nifty Smallcap index up 0.6%
  • India Volatility Index up 1% at 19.5
  • Nifty Media is the top sectoral gainer; up 1.7%
  • Nifty Auto is the other major sectoral gainer; up 1.3%
  • Nifty FMCG, Nifty Pharma and Nifty PSU Bank trade with losses
  • Adani Ports is the top Nifty gainer; up 4.7%
  • Bharti Airtel is the top Nifty laggard; down 2%
  • 943 stocks on the NSE trade with gains while 744 decline

Stock Reaction

  • TVS Motor: Shares gained as much as 7% - the most in four months to Rs 477. The stock is currently trading at the highest level in six months.
  • Hero MotoCorp: Shares gained as much as 5.2% to Rs 3,124. The stock trades at the highest level since January 2019. It is also the second best performer on the Nifty 50 index. Brokerage firm Morgan Stanley has upgraded the stock to overweight from underweight and raised its price target to Rs 3,454 from Rs 2,000.
  • Bajaj Auto: Shares gained as much as 4.3% to Rs 3,138. The stock is trading at the highest level in six months.

The rupee opened flat in today's session after recovering from the day's low on Tuesday to end little changed.

The currency opened at 74.30 against the U.S. Dollar as compared to Monday's close of 74.33.

The rupee was the third worst performing currency in Asia on Tuesday.

Within the bond market today, traders are watching for the treasury bill auction worth Rs 35,000 crore.

VA Tech Wabag Raises Rs 120 Crore From Rekha Jhunjhunwala, Two Others

Coronavirus India Updates: Tally Tops 32 Lakh As Health Ministry Touts Lower Positivity Rate

Shares gained as much as 16.7% - the most since September 2014 to Rs 62.35. The stock has snapped a three-day losing streak and is trading at a five-month high.

The housing finance division of Canara Bank reported a 24% year-on-year growth in its Net Interest Income to Rs 191.7 crore for the quarter ended June.

The company's net profit rose 15% to Rs 93.2 crore.

The non-bank lender also mentioned that it has made provisions worth Rs 72.9 crore for Covid-19 so far in the two quarters.

Shares rose as much as 8.7% to Rs 419.9. This was the biggest single-day gain for the stock in seven months. The stock is rising for the fourth straight day and is trading at the highest level in five months.

Indian equity markets opened with a positive bias for the fourth straight day, with cues from the global markets being mixed.

The S&P BSE Sensex opened 0.22% higher at 38,930 while the NSE Nifty 50 opened above the mark of 11,500 - up 0.35% at 11,512.

Among the sectoral indices - the Nifty Auto index has opened 1.2% higher after Finance Minister Nirmala Sitharaman indicated that the GST council may mull a rate cut on two-wheelers in the next GST council meeting.

Most other sectoral indices remained flat with the media index opening 0.7% higher and the realty index gaining 0.6% at the start of trade.

The Nifty Midcap index gained 0.44% while the Smallcap index is outperforming, trading with gains of 0.75%. Both midcap and smallcap index have opened higher for the seventh straight day.

1,098 stocks on the National Stock Exchange opened with gains while 354 opened with losses.

  • Total cases cross 23.8 million globally
  • Death toll rises to 8.17 lakh
  • Argentina reports 8,771 new cases - second straight rise in record cases
  • South Korea reports 320 new cases - government orders striking doctors to return to work
  • Children over the age of 11 required to wear face masks in schools in high risk areas over the U.K.
  • Overall cases in the U.S. rise 0.6%
  • Florida reports 6,05,502 new cases
  • California reports 4,480 new cases
  • 3,304 new cases reported in France while 878 new cases reported in Italy
  • U.S. FDA head acknowledged errors in comments about blood plasma therapy

To know more about earnings reported after market hours, key brokerage updates and F&O cues, click here.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search